OnKure Therapeutics, Inc. (OKUR) support and resistance · P/E 72, rev $2.0M
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
This page maps OnKure Therapeutics, Inc. (OKUR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new OKUR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the OKUR quote page for the session range and the stock page for the full model.
Not investment advice.